High dose therapy and autologous hematopoietic stem cell transplantation in septuagenarians with non-Hodgkin lymphoma: Feasible, but for which patients?

Tanya M. Wildes; Amanda Cashen

doi:10.1016/j.jgo.2015.07.001

High dose therapy and autologous hematopoietic stem cell transplantation in septuagenarians with non-Hodgkin lymphoma: Feasible, but for which patients?

Tanya M. Wildes
, Amanda Cashen

Research output: Contribution to journal › Editorial

Original language	English
Pages (from-to)	344-345
Number of pages	2
Journal	Journal of Geriatric Oncology
Volume	6
Issue number	5
DOIs	https://doi.org/10.1016/j.jgo.2015.07.001
State	Published - Sep 1 2015

Access to Document

10.1016/j.jgo.2015.07.001

Cite this

@article{77a85d37fd9a46ea82f9fad8d9422c13,

title = "High dose therapy and autologous hematopoietic stem cell transplantation in septuagenarians with non-Hodgkin lymphoma: Feasible, but for which patients?",

author = "Wildes, \{Tanya M.\} and Amanda Cashen",

note = "Funding Information: Dr. Wildes' research is supported by Grant Number 1K12CA167540 through the National Cancer Institute (NCI) at the National Institutes of Health (NIH) and Grant Number UL1 TR000448 through the Clinical and Translational Science Award (CTSA) program of the National Center for Advancing Translational Sciences (NCATS) at the National Institutes of Health . Its contents are solely the responsibility of the authors and do not necessarily represent the official view of NCI, NCATS or NIH.",

year = "2015",

month = sep,

day = "1",

doi = "10.1016/j.jgo.2015.07.001",

language = "English",

volume = "6",

pages = "344--345",

journal = "Journal of Geriatric Oncology",

issn = "1879-4068",

number = "5",

}

TY - JOUR

T1 - High dose therapy and autologous hematopoietic stem cell transplantation in septuagenarians with non-Hodgkin lymphoma

T2 - Feasible, but for which patients?

AU - Wildes, Tanya M.

AU - Cashen, Amanda

N1 - Funding Information: Dr. Wildes' research is supported by Grant Number 1K12CA167540 through the National Cancer Institute (NCI) at the National Institutes of Health (NIH) and Grant Number UL1 TR000448 through the Clinical and Translational Science Award (CTSA) program of the National Center for Advancing Translational Sciences (NCATS) at the National Institutes of Health . Its contents are solely the responsibility of the authors and do not necessarily represent the official view of NCI, NCATS or NIH.

PY - 2015/9/1

Y1 - 2015/9/1

UR - https://www.scopus.com/pages/publications/84942826388

U2 - 10.1016/j.jgo.2015.07.001

DO - 10.1016/j.jgo.2015.07.001

M3 - Editorial

C2 - 26272671

AN - SCOPUS:84942826388

SN - 1879-4068

VL - 6

SP - 344

EP - 345

JO - Journal of Geriatric Oncology

JF - Journal of Geriatric Oncology

IS - 5

ER -

High dose therapy and autologous hematopoietic stem cell transplantation in septuagenarians with non-Hodgkin lymphoma: Feasible, but for which patients?

Access to Document

Other files and links

Cite this